You just read:

ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma

News provided by

ImmunoCellular Therapeutics, Ltd.

Jul 06, 2015, 06:00 ET